Article
Single-cell genomics links CAR architectures to in vivo effector chromatin states in T cells responding to antigen-low leukemia
2026-06-29
Abstract excerpt
<title>Abstract</title> <p>Chimeric antigen receptor (CAR) T cells produce extraordinary remission rates in some hematologic malignancies, but relapses occur, often through antigen-low tumor escape. Clinical efficacy against antigen-low cancers is enhanced by modifying CAR architecture, with a drastic effect observed in CD22-CAR T cells. However, efforts to define biology driving CAR T cell responses to antigen-l...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1040f7aa-4873-5314-a6f3-347fea1a70b7
- DOI
- 10.21203/rs.3.rs-9859689/v1
